Drugs for Breast Implant-Associated Anaplastic Large Cell Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 7)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Cefazolin |
Approved |
Phase 1 |
|
25953-19-9 |
656510 33255 |
Synonyms:
(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2- yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1- yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid
(6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
25953-19-9
27164-46-1
3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid
7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid
AC-16010
AC1L1P98
AC1Q6LOT
Ancef
Bio-0576
BPBio1_000762
BRN 4169371
BSPBio_000692
BSPBio_001939
C06880
C14H14N8O4S3
Cefamedin
Cefamezin
Cefamezine
cefazolin
Cefazolin
Cefazolin (USP)
Cefazolin [USAN:INN]
Cefazolin sodium
cefazolin(usp)
Cefazolina
Cefazolina [INN-Spanish]
Cefazoline
Cefazoline [INN-French]
Cefazolinum
Cefazolinum [INN-Latin]
Cephamezine
Cephazolidin
Cephazolin
Cephazolin sodium
Cephazolin Sodium
Cephazolin, sodium
|
Cephazoline
CEZ
CHEBI:474053
CHEMBL1435
CID33255
D02299
DivK1c_000014
EINECS 247-362-8
Elzogram
Gramaxin
HSDB 3213
IDI1_000014
KBio1_000014
KBio2_000546
KBio2_003114
KBio2_005682
KBio3_001159
KBioGR_000734
KBioSS_000546
Kefzol
Lopac0_000274
LS-150084
MLS001032060
MLS001049010
MolPort-002-507-461
NCGC00159465-02
NINDS_000014
NSC291561
Prestwick0_000736
Prestwick1_000736
Prestwick2_000736
Prestwick3_000736
SMR000387025
Sodium cephazolin
Sodium, cefazolin
Sodium, cephazolin
SPBio_001039
SPBio_002631
Spectrum_000106
Spectrum2_001140
Spectrum3_000330
Spectrum4_000267
Spectrum5_000665
Totacef
UNII-IHS69L0Y4T
|
|
2 |
|
Bacitracin |
Approved, Vet_approved |
Phase 1 |
|
1405-87-4 |
439542 10909430 |
Synonyms:
(4R)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15R,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
(4R)-4-[[(2S)-2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
11702_FLUKA
11702_SIGMA
22601-59-8
4-[[2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[1-[[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
46084_RIEDEL
A.L. labs brand OF bacitracin zinc salt
AB00513964
AC1L22YV
AC1O6F67
AC1O8Q0J
AC1Q6GKZ
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
Altracin
B0125_SIGMA
Baci im
Baci RX
Baciguent
Baci-im
Baciquent
Baci-RX
Bacitin
bacitracin
Bacitracin
Bacitracin a
Bacitracin A
Bacitracin A1
Bacitracin a2a
Bacitracin A2a
Bacitracin akorn brand
Bacitracin dioptic brand
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracina
Bacitracine martinet
BPBio1_000878
|
BSPBio_000798
C15482
CHEMBL1200558
Ciba vision brand OF bacitracin
CID10909430
CID6474109
CID65281
CID6714010
Citracin
Dioptic brand OF bacitracin
EINECS 245-115-9
Fortracin
HMS1570H20
L-Asparagine, N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-.alpha.-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-.alpha.-as
Lee brand OF bacitracin
LS-23608
Martinet, bacitracine
McNeil brand OF bacitracin
MLS002695992
MolPort-003-926-019
n-{[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazol-4-yl]carbonyl}leucyl-|A-glutamyl-n-[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-(butan-2-yl)-6-(carboxymethyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl]isoleucinamide
NSC 45737
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
partyl-, (10.4)-lactam
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Prestwick1_000919
Prestwick2_000919
Prestwick3_000919
Reed and carnrick brand OF bacitracin
SMR001562136
Solu-Tracin 50
SPBio_002987
Topitracin
UNII-DDA3RRX0P7
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
3 |
|
Anti-Bacterial Agents |
|
Phase 1 |
|
|
|
4 |
|
Anti-Infective Agents, Local |
|
Phase 1 |
|
|
|
5 |
|
Gentamicins |
|
Phase 1 |
|
|
|
6 |
|
Antibiotics, Antitubercular |
|
Phase 1 |
|
|
|
7 |
|
Anti-Infective Agents |
|
Phase 1 |
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy |
Completed |
NCT03213249 |
Phase 1 |
Cefazolin;Gentamicin;Bacitracin |
2 |
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry |
Recruiting |
NCT04220970 |
|
|
3 |
Coordination of Rare Diseases at Sanford |
Recruiting |
NCT01793168 |
|
|
|